India's 500 GW clean-energy push is accelerating. One manufacturer is scaling aggressively, another is delivering superior returns. Order books are full, valuations have cooled, and 2027 could be ...

Ahead of the Union Budget 2026, experts are urging the government to significantly scale up funding for Battery Energy ...

Alternative battery technologies, hybrid energy storage, and the use of AI-based solutions drive advances in battery energy ...

Distributors and OEM brands are scrutinizing their supply chain to ensure quality and viability over the long term as the ...

JDEnergy, an industry-leading provider of distributed energy storage, has announced that its integrated PV-ESS solution, eBlock-100C, has passed the UL 9540A fire propagation test, with thermal ...

As learned from EnergyTrend, the World Future Energy Summit 2026 (WFES 2026) was held at the Abu Dhabi National Exhibition Centre from January 13 to ...

Reliance Industries ramps up its new energy ambitions, advancing large-scale solar, battery and renewable power projects as it moves from planning to execution.

New Delhi, Jan 12 (PTI) Renewable energy player Premier Energies is looking to more than double its annual cell and module manufacturing capacity to 10.6 gigawatt and 11.1 gigawatt, respectively, as ...

Optical metasurfaces, with their ultra-thin and lightweight properties, are driving the miniaturization and planarization of optical systems. However, their development from unit-cell design to system ...

SEOUL, South Korea and SHENZHEN, China and WILMINGTON, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- MBAK Energy Solutions Inc (OTC:ALYI) has begun manufacturing of battery cells as part of a BESS (Battery ...

(Reuters) -Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday. Bloomberg News first reported on ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.